Target intelligence / Profile preview

Vibrio cholerae O1 surface O-antigen lipopolysaccharide (O1 LPS)

Target
O1 LPS
Molecular classification
Bacterial surface antigen, Lipopolysaccharide, Glycan, Endotoxin, Other
01

Overview

Vibrio cholerae O1 surface O-antigen lipopolysaccharide (LPS) is a major structural and immunogenic component of the outer membrane of the Gram-negative bacterium Vibrio cholerae, the causative agent of cholera (Chatterjee & Chaudhuri, 2011, PubMed). The molecule is composed of three regions: Lipid A, a core oligosaccharide, and the O-specific polysaccharide (OSP), which is a homopolymer of 4-amino-4-deoxy-L-glycero-D-manno-heptopyranose (PubChem CID 11966243). The OSP defines the O1 serogroup and is further classified into Ogawa and Inaba serotypes based on the presence of a methyl group. As the primary target of the protective immune response, O1 LPS is the central antigen in both killed whole-cell and live-attenuated oral cholera vaccines, such as Dukoral and Vaxchora (Wierzba et al., 2015, PubMed). Antibodies directed against the OSP, particularly vibriocidal antibodies, are the best-characterized correlates of protection against cholera infection (Harris et al., 2012, PubMed). Additionally, O1 LPS serves as a critical diagnostic marker for identifying and serotyping V. cholerae strains in clinical and environmental samples (WHO, 2017).

Other names
Vibrio cholerae O1 lipopolysaccharideO-specific polysaccharideOSPV. cholerae O1 antigenO1-antigen
02

Mechanism of action

Induction of protective vibriocidal antibodies and mucosal IgA that target the O-specific polysaccharide to prevent bacterial colonization and promote pathogen clearance (Harris et al., 2012, PubMed).

03

Biological functions

Immune responseBacterial outer membrane integrityImmune evasionSerotype determinationPathogenesisOther
04

Disease associations

InfectionCholera
05

Safety considerations

EndotoxicityReactogenicitySerotype-specific immunityAge-dependent immunogenicity
06

Interacting drugs

Dukoral

4 more in the full profile.

07

Biomarkers

Serum vibriocidal antibody titerAnti-OSP IgAAnti-OSP IgGVibriocidal antibody response

Beyond the preview

Go deeper on Vibrio cholerae O1 surface O-antigen lipopolysaccharide (O1 LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae O1 surface O-antigen lipopolysaccharide (O1 LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call